These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7660448)

  • 1. Community based distribution of ivermectin in eastern Sudan: acceptability and early post-treatment reactions.
    Baraka OZ; Khier MM; Ahmed KM; Ali MM; el Mardi AE; Mahmoud BM; Ali MH; Homeida MM; Williams JF
    Trans R Soc Trop Med Hyg; 1995; 89(3):316-8. PubMed ID: 7660448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ivermectin treatment in severe asymmetric reactive onchodermatitis (sowda) in Sudan.
    Baraka OZ; Mahmoud BM; Ali MM; Ali MH; el Sheikh EA; Homeida MM; Mackenzie CD; Williams JF
    Trans R Soc Trop Med Hyg; 1995; 89(3):312-5. PubMed ID: 7660447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community-based treatment of onchocerciasis with ivermectin: acceptability and early adverse reactions.
    Pacque MC; Dukuly Z; Greene BM; Munoz B; Keyvan-Larijani E; Williams PN; Taylor HR
    Bull World Health Organ; 1989; 67(6):721-30. PubMed ID: 2633887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse reactions after community treatment of onchocerciasis with ivermectin in Guatemala.
    Zea-Flores R; Richards FO; González-Peralta C; Castro Ramirez J; Zea-Flores G; Collins RC; Cupp E
    Trans R Soc Trop Med Hyg; 1992; 86(6):663-6. PubMed ID: 1287939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Community treatment with ivermectin for onchocerciasis in the east Usambara mountains.
    Mwetta E; Hills E
    East Afr Med J; 1994 Dec; 71(12):790-1. PubMed ID: 7705249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Community-based treatment of onchocerciasis with ivermectin: safety, efficacy, and acceptability of yearly treatment.
    Pacqué M; Muñoz B; Greene BM; Taylor HR
    J Infect Dis; 1991 Feb; 163(2):381-5. PubMed ID: 1988522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ivermectin treatment of hyperreactive onchodermatitis (sowda) in Liberia.
    Darge K; Büttner DW
    Trop Med Parasitol; 1995 Dec; 46(4):206-12. PubMed ID: 8826099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse reactions to ivermectin treatment in Simulium neavei-transmitted onchocerciasis.
    Kipp W; Bamhuhiiga J; Rubaale T; Büttner DW
    Am J Trop Med Hyg; 2003 Dec; 69(6):621-3. PubMed ID: 14740878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of and compliance with community-based ivermectin therapy.
    Pacqué M; Muñoz B; Greene BM; White AT; Dukuly Z; Taylor HR
    Lancet; 1990 Jun; 335(8702):1377-80. PubMed ID: 1971669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A community trial of ivermectin for onchocerciasis in Sierra Leone: adverse reactions after the first five treatment rounds.
    Whitworth JA; Morgan D; Maude GH; Downham MD; Taylor DW
    Trans R Soc Trop Med Hyg; 1991; 85(4):501-5. PubMed ID: 1755059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The community-based treatment of onchocerciasis in Shao, Kwara State, Nigeria.
    Oyibo WA; Fagenro-Beyioku AF
    Southeast Asian J Trop Med Public Health; 2002 Sep; 33(3):496-503. PubMed ID: 12693582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse reactions to ivermectin treatment for onchocerciasis. Results of a placebo-controlled, double-blind trial in Malawi.
    Burnham GM
    Trans R Soc Trop Med Hyg; 1993; 87(3):313-7. PubMed ID: 8236405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse systemic reactions to treatment of onchocerciasis with ivermectin at normal and high doses given annually or three-monthly.
    Kamgno J; Gardon J; Gardon-Wendel N; Demanga-Ngangue ; Duke BO; Boussinesq M
    Trans R Soc Trop Med Hyg; 2004 Aug; 98(8):496-504. PubMed ID: 15186939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection.
    Gardon J; Gardon-Wendel N; Demanga-Ngangue ; Kamgno J; Chippaux JP; Boussinesq M
    Lancet; 1997 Jul; 350(9070):18-22. PubMed ID: 9217715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemokines in onchocerciasis patients after a single dose of ivermectin.
    Fendt J; Hamm DM; Banla M; Schulz-Key H; Wolf H; Helling-Giese G; Heuschkel C; Soboslay PT
    Clin Exp Immunol; 2005 Nov; 142(2):318-26. PubMed ID: 16232219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A community trial of ivermectin in the onchocerciasis focus of Asubende, Ghana. II. Adverse reactions.
    De Sole G; Awadzi K; Remme J; Dadzie KY; Ba O; Giese J; Karam M; Keita FM; Opoku NO
    Trop Med Parasitol; 1989 Sep; 40(3):375-82. PubMed ID: 2617047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction in the prevalence and intensity of infection in Onchocerca volvulus microfilariae according to ethnicity and community after 8 years of ivermectin treatment on the island of Bioko, Equatorial Guinea.
    Mas J; Ascaso C; Escaramis G; Abellana R; Duran E; Sima A; Sánchez MJ; Nkogo PR; Nguema R; Untoria MD; Echeverria MA; Ardevol MM; de Jiménez Anta MT
    Trop Med Int Health; 2006 Jul; 11(7):1082-91. PubMed ID: 16827709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ivermectin in the treatment of onchocerciasis in Britain.
    Godfrey-Faussett P; Dow C; Black ME; Bryceson AD
    Trop Med Parasitol; 1991 Jun; 42(2):82-4. PubMed ID: 1896778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A community trial of ivermectin for onchocerciasis in Sierra Leone: clinical and parasitological responses to the initial dose.
    Whitworth JA; Morgan D; Maude GH; Downham MD; Taylor DW
    Trans R Soc Trop Med Hyg; 1991; 85(1):92-6. PubMed ID: 2068774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individual host factors associated with Onchocerca volvulus microfilarial densities 15, 80 and 180 days after a first dose of ivermectin.
    Pion SD; Grout L; Kamgno J; Nana-Djeunga H; Boussinesq M
    Acta Trop; 2011 Sep; 120 Suppl 1():S91-9. PubMed ID: 20497765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.